Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06735105

Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer

Comparative Study on the Value of Three DWI Scan Sequences of 3.0T Magnetic Resonance in Staging of Gastric Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
129 (estimated)
Sponsor
Yunnan Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Accurate staging is critical for effective gastric cancer treatment planning. Conventional DWI (C-DWI) has limitations in image quality due to magnetic field inhomogeneity, which hampers precise T staging. This study aims to compare the image quality and T staging accuracy of C-DWI, TSE-DWI, and ZOOMit-DWI (Z-DWI) sequences in MRI examinations of gastric cancer patients. A prospective study plan to enroll 72 gastric cancer patients undergoing preoperative MRI with C-DWI, TSE-DWI, and Z-DWI sequences using a 3.0 T scanner. Quantitative metrics (ADC, SNR, CNR) and image quality were evaluated. T staging accuracy was assessed by comparing MRI results with postoperative pathological staging using ROC analysis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTScanning parameterBased on abdominal scanning, TSE-DWI,ZOOMIT DWI and EPI-DWI scans were performed, and the study was divided into two steps according to the nanomotion criteria. The first step was self-controlled, which was divided into experimental group and control group. The experimental group included TSE-DWI,ZOOMit DWI, and the control group included EPI-DWI. Then the image quality was evaluated by subjective and objective evaluation indexes. In the second step, the three DWI stages were performed separately by four diagnosticians, with an interval of 1 month, and statistical analysis was performed at the end.

Timeline

Start date
2023-12-23
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-12-16
Last updated
2024-12-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06735105. Inclusion in this directory is not an endorsement.